178 filings
Page 6 of 9
8-K
ejxq922g8qyl9
5 Jan 18
Entry into a Material Definitive Agreement
12:00am
8-K
jw4lib9e7 dju0
28 Dec 17
Other Events
12:00am
8-K
6pzjqsfbf084l 6z4d
1 Dec 17
Intercept Pharmaceuticals Appoints Christian Weyer as Executive Vice President of Research & Development
12:00am
8-K
nri6h
7 Nov 17
Departure of Directors or Certain Officers
12:00am
8-K
d94ph34h6 ncvzvmfwni
1 Nov 17
Intercept Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Business Update
12:00am
8-K
fokvs1z1w0 b0o8en
31 Jul 17
Intercept Pharmaceuticals Reports Second Quarter 2017 Financial Results and Provides Business Update
12:00am
8-K
7cooo4w
30 Jun 17
Submission of Matters to a Vote of Security Holders
12:00am
8-K
jfbprlzk8gmx5rmjk6qe
4 May 17
Intercept Pharmaceuticals Reports First Quarter 2017 Financial Results and Provides Business Update
12:00am
8-K
hz8x2bi yci
23 Feb 17
Intercept Pharmaceuticals Reports Full Year 2016 Financial Results and Provides Business Update
12:00am
8-K
e0fhfzc
9 Dec 16
Entry into a Material Definitive Agreement
12:00am
8-K
x5uzfn6c6is41
3 Nov 16
Intercept Pharmaceuticals Reports Third Quarter 2016 Financial Results and Provides Business Update
12:00am
8-K
q9frhpth zg6dlz
13 Oct 16
Departure of Directors or Certain Officers
12:00am
8-K
pgga m9vzrx35z1kc
12 Sep 16
Other Events
12:00am
8-K
ru3ay k6lg
18 Aug 16
Entry into a Material Definitive Agreement
12:00am
8-K
yxxqktkwmnyuup9yqf
4 Aug 16
Intercept Pharmaceuticals Reports Second Quarter 2016 Financial Results and Provides Business Update
12:00am
8-K
gknh7pi
22 Jul 16
Entry into a Material Definitive Agreement
12:00am
8-K
h9g711w2 t5syp
11 Jul 16
Departure of Directors or Certain Officers
12:00am
8-K
8zyj89ia
6 Jul 16
Intercept Pharmaceuticals Announces Pricing of Public Offering of Convertible Senior Notes
12:00am
8-K
wqm63jpwlx1py 6x
28 Jun 16
Departure of Directors or Certain Officers
12:00am
8-K
ryywsmwj c610r2vi
10 Jun 16
Intercept Pharmaceuticals Appoints Sandip Kapadia as Chief Financial Officer
12:00am